tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH

90.370USD

-1.280-1.40%
交易中 美东报价延迟15分钟
17.88B总市值
19.58市盈率 TTM

Zimmer Biomet Holdings Inc

90.370

-1.280-1.40%
关于 Zimmer Biomet Holdings Inc 公司
Zimmer Biomet Holdings, Inc. 是一家全球医疗技术公司。其部门包括美洲、欧洲、中东和非洲 (EMEA) 以及亚太地区。该公司设计、制造和销售骨科重建产品;生物制剂、运动医学、四肢和创伤 (SET) 产品;颅颌面和胸部 (CMFT) 产品;外科产品;以及一套利用数据、数据分析和人工智能的集成数字和机器人技术。其产品和解决方案有助于治疗患有骨骼、关节或支持软组织疾病或损伤的患者。其膝关节品牌包括 Persona Knee、NexGen 膝关节植入物、Vanguard Knee 和 Oxford Partial Knee。其髋关节品牌包括 Taperloc 髋关节系统、Avenir 完整髋关节系统、Arcos 模块化髋关节系统和 G7 髋臼系统。其 SET 产品类别包括运动医学、生物制剂、足部和踝关节等。
公司简介
公司代码ZBH
公司名称Zimmer Biomet Holdings Inc
上市日期Jul 25, 2001
成立日期2001
CEOMr. Ivan Tornos
员工数量17000
证券类型Ordinary Share
年结日Jul 25
公司地址345 E Main St
城市WARSAW
上市交易所NYSE Consolidated
国家United States of America
邮编46580-2746
电话15742676131
网址https://www.zimmerbiomet.com/en
公司代码ZBH
上市日期Jul 25, 2001
成立日期2001
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
19.62K
-8.40%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
2.54K
+20.36%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
48.85K
+5.46%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
19.62K
-8.40%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
9.79K
-3.72%
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Knees
792.90M
41.53%
Hips
495.80M
25.97%
S E T
470.50M
24.65%
Other product category
149.90M
7.85%
地区USD
名称
营收
占比
United States
1.11B
58.33%
International
795.50M
41.67%
业务
地区
业务USD
名称
营收
占比
Knees
792.90M
41.53%
Hips
495.80M
25.97%
S E T
470.50M
24.65%
Other product category
149.90M
7.85%
股东统计
更新时间: 19 小时前
更新时间: 19 小时前
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.61%
Dodge & Cox
10.15%
T. Rowe Price Associates, Inc.
7.16%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Global Advisors (US)
4.42%
Other
61.03%
股东类型
持股股东
占比
Investment Advisor
49.71%
Investment Advisor/Hedge Fund
34.23%
Hedge Fund
4.36%
Pension Fund
1.97%
Research Firm
1.88%
Bank and Trust
1.33%
Sovereign Wealth Fund
1.10%
Individual Investor
0.13%
Insurance Company
0.08%
Other
5.21%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1988
194.30M
98.21%
-1.70M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
2023Q1
1993
190.05M
90.59%
-15.03M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
22.96M
11.61%
+168.35K
+0.74%
Mar 31, 2025
Dodge & Cox
20.09M
10.15%
+522.66K
+2.67%
Apr 30, 2025
T. Rowe Price Associates, Inc.
14.16M
7.16%
-188.21K
-1.31%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
11.13M
5.63%
+183.28K
+1.67%
Mar 31, 2025
State Street Global Advisors (US)
8.75M
4.42%
-229.25K
-2.55%
Mar 31, 2025
American Century Investment Management, Inc.
5.25M
2.65%
-670.93K
-11.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
5.06M
2.56%
+178.23K
+3.65%
Mar 31, 2025
PRIMECAP Management Company
4.68M
2.37%
-114.18K
-2.38%
Mar 31, 2025
Columbia Threadneedle Investments (US)
4.47M
2.26%
+3.12M
+230.65%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
VanEck Morningstar Wide Moat Value ETF
4.21%
American Century Focused Large Cap Value ETF
3.05%
Leatherback Long/Short Alternative Yield ETF
2.7%
Langar Global HealthTech ETF
2.68%
VanEck Morningstar ESG Moat ETF
2.37%
VanEck Morningstar Wide Moat ETF
2.25%
iShares U.S. Medical Devices ETF
2.03%
Invesco Bloomberg Pricing Power ETF
1.8%
Cambria LargeCap Shareholder Yield ETF
1.76%
SPDR S&P Health Care Equipment ETF
1.75%
查看更多
VanEck Morningstar Wide Moat Value ETF
占比4.21%
American Century Focused Large Cap Value ETF
占比3.05%
Leatherback Long/Short Alternative Yield ETF
占比2.7%
Langar Global HealthTech ETF
占比2.68%
VanEck Morningstar ESG Moat ETF
占比2.37%
VanEck Morningstar Wide Moat ETF
占比2.25%
iShares U.S. Medical Devices ETF
占比2.03%
Invesco Bloomberg Pricing Power ETF
占比1.8%
Cambria LargeCap Shareholder Yield ETF
占比1.76%
SPDR S&P Health Care Equipment ETF
占比1.75%
分红派息
近5年累计派现 996.70M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
Aug 25, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2023 going ex on Sep 28, 2023 with reinvestment option
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 15, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2023 going ex on Jun 23, 2023 with reinvestment option
Jun 26, 2023
Jul 31, 2023
Jun 23, 2023
Mar 08, 2023
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 28, 2023 going ex on Mar 28, 2023
Mar 29, 2023
Apr 28, 2023
Mar 28, 2023
Dec 15, 2022
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 31, 2023
Dec 23, 2022
Aug 26, 2022
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI